Vaccination in cancer patients: essential guide for health protection

Mujer con cáncer usando pañuelo rosa y mascarilla recibiendo una vacuna administrada por un profesional sanitario con equipo de protección.

Table of contents

Vaccination is a fundamental tool for the prevention of infectious diseases, especially in cancer patients. People undergoing cancer treatment often have a compromised immune system, which makes them more susceptible to serious infections.

Infections can complicate treatment, delay chemotherapy or immunotherapy doses, slow recovery, and even put the patient’s life at risk. Therefore, it is essential to understand the importance of vaccination in these patients, as it can provide an additional form of protection against dangerous infections.

 

Why is vaccination important in cancer patients?

The impact of cancer and treatments on the immune system 

Cancer and cancer treatments, such as chemotherapy, radiation therapy, or immunotherapy, can weaken or alter the patient’s immune system, leaving them more vulnerable to infections. Treatment can reduce the production of white blood cells, which are crucial for fighting infections, or affect the body’s ability to recognize and eliminate pathogens.

Risks of infections in immunocompromised patients 

Cancer patients face a higher risk of infections, which can be more severe and difficult to treat due to their compromised immune system. Common infections, such as the flu, respiratory infections, or viral gastroenteritis, can lead to serious complications, such as pneumonia, which delay cancer treatment or worsen the prognosis.

Benefits of vaccination in the prevention of serious diseases 

Vaccination in cancer patients offers additional protection against serious diseases. Vaccines stimulate the immune system to produce a response that defends the body against specific pathogens. By receiving the appropriate vaccines, patients can reduce their risk of contracting dangerous infectious diseases that could interfere with their treatment or overall health.

 

Recommended vaccines for cancer patients 

Inactivated vaccines 

Inactivated vaccines are generally safe for cancer patients, as they do not contain live microorganisms and cannot cause the disease they are intended to prevent. Among the most recommended are:

  • Diphtheria, tetanus, pertussis (dTpa or Td): It is advisable to check previous vaccination status and assess individual risk of tetanus before starting or completing a primary vaccination series with Td in adults.
  • Inactivated influenza: the influenza vaccine is very important, especially in winter, to prevent serious respiratory infections. One dose of inactivated vaccine should be given each season, at least for the first three seasons after chemotherapy.
  • Pneumococcus: vaccination is indicated to protect against invasive disease and pneumonia caused by Streptococcus pneumoniae, diseases that can be especially dangerous in people with weakened immune systems. The administration of a sequential schedule will be assessed according to the pathology and the vaccines available.
  • Hepatitis B: The hepatitis B vaccine is essential, as cancer patients are more susceptible to viral infections. A serological test should be performed before receiving cancer treatment and the risk of exposure to the virus should be assessed.
  • COVID-19: COVID-19 vaccines are recommended for all cancer patients, as this disease can be particularly severe in people with compromised immune systems. One dose will be administered each season, although people with a high degree of immunosuppression may require an additional dose.
  • Shingles: This disease is caused by the reactivation of the varicella zoster virus, so anyone who has previously had chickenpox may develop shingles. Cancer patients, due to immunosuppression caused by their own disease or by the immunosuppressive treatments they receive, have an increased risk of developing HZ and serious complications, such as postherpetic neuralgia, ophthalmic, neurological, or cardiovascular effects. Therefore, the herpes zoster vaccine is highly recommended for cancer patients, as it reduces the risk of developing the disease and complications.

Cancer patients who have undergone splenectomy (removal of the spleen) due to the presence of metastases require specific vaccination to prevent infections by encapsulated germs. In addition to the above, these individuals are recommended to receive the following vaccines:

  • Meningococcus ACWY: administer 2 doses, with a minimum interval of 4 weeks between doses. A booster dose should be administered at 5 years of age, and the need for subsequent booster doses should be assessed.
  • Meningococcus B: administer 2 doses, with a minimum interval of 4 weeks between doses. A booster dose should be administered one year after completion of the primary vaccination series, followed by a booster dose every 5 years.
  • Haemophilus influenzae type b (Hib): a single dose should be administered regardless of age.

Attenuated vaccines: are they safe? 

Attenuated vaccines contain weakened live viruses. Although they are effective, they are contraindicated in patients with compromised immune systems. In general, they should be avoided, except in specific cases where the oncologist authorizes them. Examples of attenuated vaccines include:

  • Measles, mumps, and rubella (MMR).
  • Chickenpox.
  • Rotavirus.

In these cases, the oncologist will assess the risk and decide whether vaccination is appropriate and when is the best time to do it, depending on the type of treatment the patient is receiving.

 

The right time to vaccinate cancer patients 

The ideal time to get vaccinated varies depending on the type of cancer treatment. In general, vaccines should be given before starting treatment or during periods when the immune system is strong enough to respond adequately. It is important to follow the oncologist’s instructions, as some vaccines may need to be given in additional doses or at specific times during treatment.

In general, inactivated vaccines should be administered at least 2 weeks before the start of immunosuppression and between 3 and 6 months after the end of immunosuppression. Attenuated vaccines should be administered at least 4 weeks before the start of immunosuppression and between 3 and 24 months after the end of immunosuppression, and are contraindicated throughout the period of immunosuppression.

Sometimes, depending on the type of cancer and the treatment they receive, cancer patients may require additional doses and boosters, so each case must be evaluated individually.

People who are vaccinated without observing the recommended minimum intervals or who are vaccinated during treatment should be considered as possible “non-responders,” and the advisability of receiving a booster should be assessed.

 

Vaccination and cancer treatments: special considerations 

Impact of cancer treatments on vaccine response 

Treatments such as chemotherapy, radiotherapy, and immunotherapy can affect the immune system’s ability to respond to vaccines. Patients undergoing chemotherapy, for example, may not generate an effective immune response if the vaccine is administered during a period of immunosuppression.

Periods when certain vaccines should be avoided 

It is crucial that cancer patients consult with their oncologist before receiving any vaccine. During some treatments, such as chemotherapy, it may be necessary to wait until the immune system recovers before administering certain vaccines. Vaccination with live attenuated viruses should also be avoided during these periods.

Importance of consulting with your oncologist before getting vaccinated 

Consultation with the oncologist is essential to determine the appropriate timing and vaccines for each patient, as treatments can affect the immune response and vaccination options.

 

Myths and facts about vaccination in cancer patients 

  • Can vaccines cause more serious adverse effects in cancer patients?

No, vaccines do not generally cause serious adverse effects, even in cancer patients. However, due to the nature of their treatments, some patients may experience side effects, most of which are mild or temporary, such as fever, muscle aches, or pain at the injection site.

  • If I am undergoing treatment, should I not get vaccinated?

It is not true that cancer patients should not get vaccinated during treatment. In fact, vaccination is essential to protect patients from infectious diseases. The key is to coordinate the right time for vaccination with your oncologist, who will evaluate each case individually.

  • Can vaccines interfere with cancer therapy?

Vaccines do not generally interfere with cancer treatments. However, they should be administered at specific times and, as mentioned above, certain vaccines, such as live virus vaccines, should be avoided during periods of immunosuppression.

 

Recommendations for family members and caregivers 

Importance of vaccination in the patient’s environment 

In order to reduce the chances of infection in cancer patients, it is vital that their family members, cohabitants, and caregivers keep their vaccination schedules up to date according to their age, with special emphasis on vaccination against influenza, pneumonia, and COVID-19, as well as against MMR and chickenpox, depending on the age of the cohabitant. This protects the patient by minimizing the chances of exposure to external infections.

As an additional precaution in immunocompromised patients (due to disease or treatment), after a child living with them has been vaccinated with certain vaccines, the following measures should be taken to prevent possible transmission of the vaccine virus to the patient:

  • Rotavirus vaccine (oral): avoid any contact with the infant’s stool for 4 weeks after vaccination.
  • Chickenpox vaccine: if the person living with the patient develops a rash after vaccination, contact with the lesions should be avoided.
  • Oral vaccines against polio and Salmonella typhi T and 21 are contraindicated in people living with the patient.
  • The intranasal flu vaccine (live attenuated) can be used in contacts.

Vaccination is a key protective measure for cancer patients, helping to prevent serious infections that could complicate their treatment and overall health. It is essential that patients consult with their oncologist before receiving any vaccine to ensure that it is safe and appropriate for their situation. By protecting patients with the right vaccines, unnecessary complications can be prevented and quality of life during cancer treatment can be improved.

Dr. Rosa María Morera

Radiation Oncology

  • Specialist in Radiation Oncology.
  • Degree in Medicine and Surgery.  Faculty of Medicine, Complutense University of Madrid (2-8-1990).
  • Head of the Radiation Oncology Department, Hospital Universitario La Paz, Madrid.
  • Expert with university micro-credential mention in Physics, Technology and Protontherapy. King Juan Carlos University.
  • Higher University Course in Design and Management of Proton Therapy Centres. King Juan Carlos University.
  • XIX Programme of Senior Management in Health Institutions. IESE Business School. University of Navarra.
  • Master in Administration and Management of Health Services XXIV Edition (2013-2014). Pompeu Fabra University.
  • Doctoral Thesis Reading: ‘Radical thoracic irradiation and pulmonary functional study in patients with locally advanced non-small cell lung cancer. Systematic review and prospective case series’ . Qualification of outstanding ‘cum laude’.
  • Doctorate courses: Complutense University of Madrid (1995-1997).
  • She is a researcher in numerous clinical trials, publishing several national and international scientific articles.

Dr. Jose María Oliver

Breast radiology

  • Breast radiologist and specialist in cryoblation of breast lesions in the IVOQA Breast Unit.
  • Degree in Medicine and Surgery from the University of Navarra (1983-1989). Specialisation via MIR in Radiology. Number 289.
  • Specialist in radiology in several renowned hospitals, international reference and pioneer in the application of cryoablation to breast pathology in Spain.
  • Head of the Breast Radiology Section at the Hospital Universitario La Paz.
  • Member of the Spanish Society of Medical Radiology (SERAM) and the Spanish Society of Diagnostic Imaging (SEDIM).

Dr. Jesús Cañete Gómez

General and Digestive Surgery. Oncological Surgery

  • Graduate in Medicine and Surgery from the University of Seville (2000- 2006).
  • Specialist in colon and rectal cancer surgery using a minimally invasive approach.
  • Training in transanal rectal cancer treatment (TAMIS and TaTME).
    Training in minimally invasive surgery at Jackson Memorial Hospital (Miami).
  • Specialist in General Surgery at Viamed Fatima Hospital, Seville (currently).
  • Doctor of Medicine from the University of Seville (‘cum laude’).
  • Associate Professor at the University of Seville Founder of the surgical team Laparoscopic Surgery Seville – MISS (Minimally Invasive Surgical Solutions) – minimally invasive surgical techniques in scheduled and emergency surgery.
  • He has written numerous publications in journals and books and is a member of the Spanish Society of Obesity Surgery (SECO), as well as the Spanish Association of Surgeons (AEC) and the Andalusian Association of Surgeons (ASAC).

Dr. Juan José Segura Sampedro

General and digestive surgery. Oncological Surgery

  • Degree in Medicine and Surgery from the University of Seville. 2003-2009.
  • Specialist in peritoneal carinomatosis.
  • Doctor of Medicine from the University of Seville (‘cum laude’).
  • Oncological Surgeon in the Section of Peritoneal, Retroperitoneal and Soft Parts Oncological Surgery, Department of General and Digestive System Surgery, Hospital Universitario La Paz, Madrid.
  • Associate Professor of Surgery, Faculty of Medicine, University of the Balearic Islands, Palma de Mallorca.
  • 3IP in the Research Group in Advanced Oncological Surgery, m-Health and Innovation in Surgical Technology, Institute for Health Research of the Balearic Islands (IdISBa), Palma de Mallorca.
  • He has written numerous publications in journals and books and is a member of the Spanish Society of Surgical Oncology (SEOQ), the Spanish Society of Coloproctology (AECP), the Spanish Association of Surgeons (AEC), the European Society of Oncological Surgery (ESSO) and the Spanish Group of Peritoneal Oncological Surgery (GECOP).

Pablo Soto

Specialist in sports training for oncology patients

  • Higher Degree in Dietetics (2020-2022)
  • Treatment and rehabilitation of cancer patients

Dr. Gonzalez Larriba

Medical oncology

  • Professor of Medical Oncology at the Complutense University of Madrid
  • Head of the Medical Oncology Section of the Hospital Clínico San Carlos in possession of the European Certificate in Oncology
  • Recognition of 6 six-year research periods + 1 six-year period of knowledge transfer
  • Master in Oncology Services Management by the University of Alcala de Henares
  • Visiting Professor of Oncology at the University of Palermo (Italy)
  • Multiple stays in international centres (Memorial Sloan Kettering Cancer Center, Gustave Roussy Institute, University of Lyon, Princess Margaret Hospital in Toronto, University of Pittsburgh)
  • Maximum recognition of the Professional Career by the Regional Ministry of Health of the Community of Madrid
  • Director of the Master’s Degree in Genitourinary Tumours at the Complutense University of Madrid
  • Founder and member of the Board of Directors of the Spanish Lung Cancer Group, Spanish Genitourinary Tumour Group and Spanish Melanoma Group
  • Member of the Board of Directors of the Spanish Society of Medical Oncology
  • Miembro de la European Society of Medical Oncology, American Society of Clinical Oncology, International Association for the Study od Lung Cancer, etc.
  • Author of more than 300 scientific articles, 400 conference papers and 60 scientific books, as well as speaker in more than 400 conference papers

Francisco Flores

Physiotherapy

  • Graduate in physiotherapy. UEM.
  • Master’s degree in respiratory physiotherapy. UNIVERSITAT
  • ROVIRA i VIRGILI.
  • MASTER specialist in conservative and invasive physiotherapy of myofascial pain syndrome and fibromyalgia. UAH.
  • SPIROMETRIST by the ERS-SEPAR for the performance and interpretation of SPIROMETRY.
  • MASTER Specialist in intratissue percutaneous electrolysis treatments EPI.
  • Specialist in the use and application of the INDIBA ACTIV system.
  • MASTER Specialist in Biomechanical Analysis, Intervention and Treatment “Check yourMOtion”.
  • NATIONAL CLASSIFIER for athletes with cerebral palsy.
  • NATIONAL CLASSIFIER of athletics for people with physical disabilities.
  • RESEARCH PROJECT: “Respiratory physiotherapy as a treatment for ARVC in high performance athletes”.

Dr. Javier Heras Aznar

BREAST UNIT

  • Graduate in Medicine and Surgery from Universidad Autonoma de Madrid 1992.
  • Specialist via MIR in Family Medicine at Hospital Universitario Ramón y Cajal 1994-1996.
  • Specialist via MIR in OBSTETRICS AND GYNECOLOGY at Hospital Universitario Santa Cristina in Madrid 1997-2001.
  • Specialized in the last 27 years in Gynecological Oncology and Breast Pathology, both malignant and benign, with experience in Oncoplastic Surgery.
  • Specialization Course in Oncoplastic Breast Surgery 2015.
  • Coordinator of the Breast Unit and the Breast Tumors and Gynecology Oncology Committee in Hospital Universitario Infanta Sofía.
  • Main Author of the Breast Unit Accreditation Project (Hospital Universitario Infanta Sofía) 2019-2020.

Dr. Beatriz García-Conde

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery.
  • MIR specialisation in Digestive System Medicine, Puerta de Hierro University Hospital in Majadahonda. Currently working at the 12 de Octubre University Hospital.
  • Specialist in capsule endoscopy and in diagnostic and therapeutic endoscopy: chromoendoscopy, colon cancer screening, digestive dilatations, PEG placement, endoluminal vacuum therapy (fistulas/leaks), polypectomy/mucosectomy.
  • She also a general digestive consultant with a Master’s Degree in Neurogastroenterology.

Dr. Micaela Riat Castro Zocchi

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery.
  • MIR specialisation in Digestive System Medicine, Princesa Hospital (Madrid).
  • Clinical consultation. Diagnostic and therapeutic endoscopy: Chromoendoscopy, Colon Cancer Screening, Placement of digestive prosthesis (oesophagus, colon), Digestive dilatations, PEG Placement, Endoluminal Vacuum Therapy (fistulas/leaks), Polypectomy/mucosectomy. Experience in Bariatric Endoscopy: Intragastric balloon.

Dr. Diana Fresneda Cuesta

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery.
  • MIR specialisation in Digestive System Medicine, Jiménez Díaz Foundation. (Madrid)
  • Clinical consultation. Specialist in Endoscopic Capsule and in Diagnostic and Therapeutic Endoscopy: Chromoendoscopy, Colon Cancer Screening, Ligation of Oesophagus Varices, Placement of digestive prosthesis (oesophagus, colon), Digestive dilatations, PEG Placement, Endoluminal Vacuum Therapy (fistulas/leaks), Polypectomy/mucosectomy. Experience in bariatric endoscopy: intragastric balloon, POSE method and Endo-sleeve with POSE system, etc.

Dr. Teresa Valdés Lacasa

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery
  • MIR specialisation in Digestive System Medicine, 12 de Octubre University Hospital (Madrid). Advanced Endoscopy Fellowship (ERCP and digestive prostheses) at Ninewells Hospital (United Kingdom). 2020-2021.
  • Clinical consultation and abdominal ultrasound.
  • Specialist in pancreatico-biliary conditions and therapeutic endoscopy: ERCP, placement of digestive prostheses (oesophagus, duodenum, colon, biliary), digestive dilatations, placement of PEGs, endoluminal vacuum therapy (fistulas/leaks), polypectomy/mucosectomy.

Dr. Andrés J. del Pozo García, MD. PhD.

DUAL SPECIALISATION IN DIGESTIVE SYSTEM MEDICINE / FAMILY AND COMMUNITY MEDICINE

  • Graduate in Medicine and Surgery.
  • Dual specialised training (MIR) at the Princesa University Hospital (Madrid).
  • Specialist in Digestive System Medicine and Specialised in Family and Community Medicine
  • PhD in Medicine from the Autonomous University of Madrid. Cum Laude. 2020.
  • Member of S.E.P.D, S.E.E.D., A.E.G, E.S.G.E, AESPANC, Board Member of GETTEMO; Consultant of Apollo Endosurgery in 2021.

Dr. José María Abadal Villayandre

SPECIALIST IN VASCULAR INTERVENTIONAL RADIOLOGY

  • Graduate in Medicine and Surgery from Navarra University.
  • MIR specialisation in Radiology, Radiodiagnosis at Gregorio Marañón University Hospital.
  • PhD in Radiodiagnosis from the Complutense University of Madrid. Cum Laude Doctoral Thesis.
  • Specialist in Vascular Interventional Radiology, accreditation from the Spanish Society of Interventional Radiology.
  • European Board Interventional Radiology (EBIR) Health Sciences) at Alfonso X el Sabio University. 2010-2014.
  • Medical Director of the “Centro de Radiología y Diagnóstico por Imagen”.
  • Scientific and research activity with numerous publications and research studies.
  • Director and professor of Interventional Vascular Radiology at the I-XI Endo-school. Teaching activity.
  • Member of SERAM (Spanish Society of Medical Radiology), CIRSE (Cardiovascular Interventional Radiology Society Europe), and Secretary of SERVEI (Spanish Society of Interventional Vascular Radiology).

Belén Pérez Peiro. Psychologist

SPECIALIST IN PSYCHO-ONCOLOGY

  • Graduate in Psychology
  • Clinical psychologist, Gregorio Marañón University General Hospital, Psycho-oncology, Gynaecological Psychology, Neuropsychology, Detoxification and Out-patient Hospital, inflammatory bowel disease and teenagers.
  • Clinical activity at the Niño Jesús Children’s University Hospital, Psychiatric and Eating Disorder Units.
  • Expert qualification in Psychosomatic Medicine and Health Psychology.
  • Expert qualification in Psychopathology and Psychiatry from the Spanish Society of Psychosomatic Medicine and Medical Psychology.
  • Specialist qualification in Psychotherapy and projective techniques, both of which are recognised by the Madrid Official Association of Psychologists.

Dr. Ana María Moreno

SPECIALIST IN INTERNAL MEDICINE AND NUTRITIONAL PREHABILITATION

  • Graduate in Medicine and Surgery. 1986– 1992.
  • Extraordinary Graduation Award. 1992.
  • MIR specialisation in Internal Medicine. Number 283.
  • Master’s Degree in Palliative Care from Valladolid University. 2011.
  • University Master’s Degree in Advanced Chronic Nursing and palliative care from Antonio de Nebrija University. 2017.
  • PhD Courses 1993.
  • Extensive professional career in many renowned hospitals.
  • Head of Internal Medicine Services at Viamed Santa Elena (Madrid). September 2021 – Present.
  • Teaching and research work.
  • Numerous publications and papers. Participation in courses and seminars.